Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have created a novel microfluidic platform that can assess women’s breast cancer risk at the cellular level. The first-of-its-kind platform squeezes individual breast epithelial cells, creating a taxing environment to measure how they deform, recover, and behave under stress, according to a new study published in eBioMedicine.
This article was originally published on MedicalXpress.com
